Results 141 to 150 of about 14,945 (175)

Managing Yao Syndrome: A Case of Beneficial Treatment with Upadacitinib and Leflunomide. [PDF]

Mediterr J Rheumatol
Hasbani GE, Davis JM.
europepmc   +1 more source

TNF Receptor-Associated Periodic Syndrome: An Analysis of a Slovakian Cohort of TRAPS Patients. [PDF]

Arch Rheumatol
Slenker B, Banovcin P, Hrubiskova K, Vargova V, Bobcakova A, Gensor D, Malicherova Jurkova E, Kapustova D, Kapustova L, Markocsy A, Petrovicova O, Jesenak M.   +11 more
europepmc   +1 more source

Canakinumab for the treatment of postprandial hypoglycaemia: study protocol for a randomised, placebo-controlled, parallel-group, double-blind, multicentric, superiority trial-the CanpHy study. [PDF]

BMJ Open
Hepprich M, Fischer J, Cattaneo M, Ferreira A, Herzig D, Bally L, Donath M.   +6 more
europepmc   +1 more source

A systems biology approach to identify key targets in KRAS/BRAF-mutated colorectal cancer. [PDF]

Discov Oncol
Shiravi S, Mottaghi-Dastjerdi N, Shahbazi B, Ahmadi N, Soltany-Rezaee-Rad M, Ghorbani A, Montazeri H.   +6 more
europepmc   +1 more source

Demystifying the diagnosis and management of ICUS, CHIP, and CCUS. [PDF]

Hematology Am Soc Hematol Educ Program
Xie Z, Lee DH, Hansen DK, Loghavi S.
europepmc   +1 more source

Mechanistic role of the IL-1β/c-Fos/NFATc1 signaling axis in echinococcal infection-promoted osteoclast differentiation and activation in pathological osteolysis: a prospective controlled trial. [PDF]

J Orthop Surg Res
Ayiheng Y, Mahan W, Xie Z.
europepmc   +1 more source

Firsekibart as a Prophylactic Treatment for Acute Gout Flare in Participants Initiating Urate-Lowering Therapy: A Phase 2, Randomized, Open-Label, Multicenter, Active-Controlled Trial. [PDF]

ACR Open Rheumatol
Yu Y, Xue Y, Hu J, Zhang N, Li R, Guo H, Qian L, Gou W, Yang J, Mao L, Yu J, Liu S, Xu Q, Luo T, Zou H.   +14 more
europepmc   +1 more source

Muckle Wells syndrome as an example of hereditary systemic autoinflammatory disease [PDF]

, 2014
Bertomeu Tomàs, Andrea, Universitat Autònoma de Barcelona. Facultat de Biociències   +1 more
core  

OR10-006 - Canakinumab in patients with TRAPS [PDF]

core   +1 more source

Genomics-driven drug repurposing and novel targets identification for sickle cell disease in Saudi patients. [PDF]

Front Bioinform
Alghubayshi A, Alshabeeb MA, Wijesinghe D, AlAwadh M, Alshammari S, Alrajeh K, Alkhairi MA, Islam I, Alaskar A.   +8 more
europepmc   +1 more source